CD19 and lymphoma: Figure 3C depicts the specific lysis of irradiated and non-irradiated CAR NK-92 after a 4 h co-culture with Daudi and Namalwa lymphoma cell lines (both CD19+ and BCMA+), and with the U266 myeloma cell line (CD19− and BCMA+) at an E:T ratio of 1:1.